proprietary algorithms, data pipelines, and machine learning models to interpret complex genetic data. These tools are used to identify genetic variants that influence drug response and to translate findings into actionable clinical insights. Lev Hai Genetics targets healthcare organizations, clinicians, and research partners seeking to incorporate pharmacogenomic information into treatment decisions. Its work is positioned within the broader fields of biotechnology and natural sciences, with an emphasis on genetic-based drug optimization and diagnostic development.